Compounded GLP1 Weight
Management Medications
Compounded GLP1
Weight Management Medications
Semaglutide & Tirzepatide (Injectable Options) Clinically proven GLP1 medications designed to support sustainable weight loss, appetite control, and improved metabolic health.
Overview
Compounded GLP1 medications replicate the active pharmaceutical ingredients found in leading weight management therapies. These formulations are prepared by licensed compounding pharmacies and delivered through our telehealth workflow.
Both Semaglutide and Tirzepatide work by activating incretin pathways that regulate appetite, blood sugar, and metabolic rate — but each has unique characteristics that may make one more suitable depending on the patient’s goals.
Semaglutide
(Compounded Injectable)
Category: GLP1 receptor agonist
Dosing: Weekly injection
Best for: Appetite suppression, steady weight loss, metabolic regulation
What it does:
- Reduces appetite and cravings
- Slows gastric emptying
- Helps regulate blood sugar
- Supports consistent weekly weight loss
- Often preferred by patients who want a gentler, predictable progression
Why patients choose Semaglutide:
- Strong appetite control
- Lower incidence of GI side effects compared to dual agonists
- Typically more affordable
- Ideal for first time GLP1 users
Tirzepatide
(Compounded Injectable)
Category: Dual GIP + GLP1 receptor agonist
Dosing: Weekly injection
Best for: Faster weight loss, enhanced metabolic impact, insulin sensitivity
What it does:
- Activates both GLP1 and GIP pathways
- Produces stronger appetite suppression
- Improves insulin sensitivity
- Often results in more rapid weight loss compared to Semaglutide
- Preferred by patients who want maximum metabolic impact
Why patients choose Tirzepatide:
- Faster weight reduction
- Stronger metabolic improvements
- Enhanced energy and appetite control
- Ideal for patients who have plateaued on Semaglutide or want more aggressive results
Semaglutide vs. Tirzepatide
| Feature | Semaglutide | Tirzepatide |
|---|---|---|
| Mechanism | GLP1 only | GLP1 + GIP dual agonist |
| Speed of weight loss | Moderate | Fast |
| Appetite suppression | Strong | Very Strong |
| GI side effects | Mild–moderate | Moderate |
| Cost | Lower | Higher |
| Best for | First time GLP1 users, steady progress | Maximum results, metabolic optimization |
Bottom line:
Semaglutide = steady, predictable, cost effective
Tirzepatide = faster, stronger, dual pathway results
How Our Compounded GLP1s Are Made
- Prepared by licensed compounding pharmacies
- Sterile, injectable formulations
- Produced in controlled environments following USP standards
- Each batch undergoes potency, sterility, and endotoxin testing
- Delivered through our telehealth workflow with medical oversight
Who These Medications Are For
Patients seeking medically supported weight loss who may benefit from:
- Reduced appetite
- Improved metabolic function
- Better blood sugar control
- Sustainable weekly weight reduction
- A structured dosing plan with clinical guidance
What’s Included
- Telehealth consultation
- Prescription facilitation
- Compounded medication supply
- Injection instructions
- Ongoing support and dose adjustments
- Free Shipping
FAQ
GLP1 medications activate incretin pathways that help regulate appetite, blood sugar, and metabolic rate. They support weight management by reducing hunger, slowing digestion, and improving metabolic efficiency. Tirzepatide also activates the GIP pathway, which can enhance metabolic effects.
GLP1 medications have been widely studied and used under medical supervision. They must be prescribed by a licensed clinician. If you have any health concerns or underlying conditions, a qualified healthcare professional can help determine whether these medications are appropriate for you.
Both Semaglutide and Tirzepatide are administered as once weekly subcutaneous injections. Patients receive instructions on proper injection technique, storage, and handling. If you're unsure about injection procedures, a clinician can provide guidance.
Compounded medications are prepared by licensed compounding pharmacies and are not identical to brandname products. They replicate the active pharmaceutical ingredients and are produced for patients who require customized formulations. Compounded medications are made in controlled environments and undergo sterility and potency testing.
- Complete your online intake
- A clinician reviews your information
- If appropriate, a prescription is issued
- The pharmacy compounds your medication
- Your order is shipped with instructions and support
GLP1 injectables are typically stored refrigerated. Your medication will arrive with storage instructions. If you have questions about handling or temperature requirements, a clinician or pharmacist can provide guidance.
GLP1 medications may not be appropriate for individuals with certain medical conditions. A clinician will review your health history to determine suitability. If you have concerns about your health, it's important to speak with a qualified healthcare professional.
Duration varies. Some patients use GLP1s short term to reach a goal, while others continue longer for ongoing support. A clinician can help determine an appropriate timeline based on your health needs.
Alcohol may increase nausea or affect blood sugar. If you have questions about alcohol use and your health, a qualified healthcare professional can provide guidance.
Semaglutide is often preferred for steady, predictable progress. Tirzepatide is often chosen for faster, more aggressive results. A clinician will help determine which option aligns with your health profile and goals.
Semaglutide is a GLP1 agonist. Tirzepatide is a dual GLP1 + GIP agonist. Semaglutide typically produces steady, predictable weight loss. Tirzepatide often produces faster and more pronounced results due to its dual pathway mechanism.
Patients may experience:
- Mild nausea
- Reduced appetite
- Digestive changes
- Occasional fatigue
These effects are typically dose dependent and often decrease as the body adjusts. If symptoms persist or worsen, a healthcare professional should be consulted.
Most patients begin noticing appetite changes within the first few weeks. Weight changes vary depending on individual factors, lifestyle, and medication type. Tirzepatide often produces faster results, but both medications support gradual, sustainable progress.
Yes. A licensed clinician must review your intake, assess your medical history, and determine whether GLP1 therapy is appropriate. This is done through our telehealth workflow.
Many patients transition from Semaglutide to Tirzepatide if they want stronger appetite control or faster results. Any switch should be discussed with a qualified healthcare professional to ensure safe and appropriate dosing.
General guidance is to take the dose when you remember, as long as it's not too close to your next scheduled dose. For specific instructions, a healthcare professional should be consulted.
GLP1 medications support appetite control and metabolic regulation, but lifestyle habits still influence results. Many patients find it easier to maintain healthier routines once appetite is reduced.
Yes. Licensed compounding pharmacies perform:
- Sterility testing
- Potency verification
- Endotoxin testing
- Batch specific quality checks
This ensures the medication meets required standards before shipping.
GLP1 medications are known to influence blood sugar regulation. If you have diabetes or prediabetes, a clinician can evaluate whether GLP1 therapy is appropriate and safe for your situation.
Click Start Your Consultation on GenericMedicine.com, complete your intake, and a clinician will review your information. If appropriate, your medication will be prepared and shipped.
